Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Roivant Sciences Ltd
(NQ:
ROIV
)
11.55
-0.02 (-0.13%)
Streaming Delayed Price
Updated: 3:09 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Roivant Sciences Ltd
< Previous
1
2
3
4
5
6
7
Next >
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
December 01, 2022
From
Roivant Sciences
Via
GlobeNewswire
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
November 15, 2022
Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in...
Via
Benzinga
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
November 15, 2022
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
Via
Benzinga
Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update
November 14, 2022
From
Roivant Sciences
Via
GlobeNewswire
Analyst Ratings for Roivant Sciences
June 29, 2022
Within the last quarter, Roivant Sciences (NASDAQ:ROIV) has observed the following analyst ratings:
Via
Benzinga
Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases
June 28, 2022
Via
Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
On Wednesday, 807 companies reached new 52-week lows.
Via
Benzinga
Affivant to Present Data on AFVT-2101 at 37th Annual Meeting of SITC
November 10, 2022
From
Roivant Sciences
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 08, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.
Via
Benzinga
Roivant Sciences Announces Pricing of Primary and Secondary Public Equity Offering
November 08, 2022
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Announces Proposed Public Equity Offering
November 07, 2022
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences to Report Financial Results for the Second Quarter Ended September 30, 2022 on Monday, November 14, 2022 and Present at Upcoming Conferences
October 18, 2022
From
Roivant Sciences
Via
GlobeNewswire
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
October 07, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
October 06, 2022
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
Via
Benzinga
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
Via
Benzinga
Expert Ratings for Roivant Sciences
August 16, 2022
Over the past 3 months, 4 analysts have published their opinion on Roivant Sciences (NASDAQ:ROIV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
JELD-WEN, Royal Caribbean Cruises And Some Other Big Stocks Moving Lower On Monday
August 01, 2022
FiscalNote Holdings Inc. (NYSE: NOTE) fell 22.7% to $6.43. FiscalNote closed its earlier-announced agreement to acquire Aicel Technologies.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 18, 2022
Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.
Via
Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
June 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Earnings Scheduled For June 28, 2022
June 28, 2022
Companies Reporting Before The Bell • Jupai Hldgs (NYSE:JP) is projected to report earnings for its first quarter.
Via
Benzinga
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
June 28, 2022
From
Pfizer Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
June 17, 2022
Gainers Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value of their outstanding shares is at $1.8 billion.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 25, 2022
Via
Benzinga
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
May 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
May 23, 2022
Via
Benzinga
110 Biggest Movers From Friday
May 16, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022
April 29, 2022
Upgrades
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.